Medivir strengthens the business development potential of remetinostat through renegotiated multi-party agreement ...Middle East

PR Newswire - News
Medivir strengthens the business development potential of remetinostat through renegotiated multi-party agreement
HUDDINGE, Sweden, Aug. 16, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announced today that Medivir AB ("Medivir" or "the Company") together with the originators of remetinostat, and TetraLogic Pharmaceuticals Corporation and The Leukemia & Lymphoma Society ("the...

Hence then, the article about medivir strengthens the business development potential of remetinostat through renegotiated multi party agreement was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medivir strengthens the business development potential of remetinostat through renegotiated multi-party agreement )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News